Evaluation of Se-phenyl-thiazolidine-4-carboselenoate protective activity against oxidative and behavioral stress in the maniac model induced by ouabain in male rats

Neurosci Lett. 2017 Jun 9:651:182-187. doi: 10.1016/j.neulet.2017.04.030. Epub 2017 Apr 19.

Abstract

This study investigates Se-phenyl-thiazolidine-4-carboselenoate (Se-PTC) protective activity against oxidative and behavioral stress in the model of mania induced by ouabain (OUA) in male rats. The compound used was Se-PTC (50mg/kg) and the positive control LiCl (45mg/kg) was administered for intragastric route (i.g.) 30min prior to administration of OUA (10-5M). OUA was dissolved in artificial cerebrospinal fluid (aCSF) and administered at the 5μl through an intracerebroventricular (i.c.v) cannula. The pretreatment with Se-PTC was effective in preventing the increase in locomotor activity induced by OUA, however the positive control LiCl is capable to block crossing augmentation induced by OUA. Na+/K+-ATPase activity was significantly reduced in OUA group and the Se-PTC to normalize Na+/K+-ATPase activity. Pretreatment with Se-PTC protect against the increase in catalase activity and thiobarbituric acid reactive species (TBARS) content in the brain caused by OUA. Therefore, Se-PTC is effective against OUA-induced hyperactivity and alterations in brain oxidative status of rats.

Keywords: Bipolar; Mania; Organoselenium; Oxidative stress; Selenium.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Behavior, Animal / drug effects*
  • Bipolar Disorder / chemically induced
  • Bipolar Disorder / drug therapy*
  • Bipolar Disorder / metabolism*
  • Brain / drug effects*
  • Brain / metabolism
  • Disease Models, Animal
  • Locomotion / drug effects
  • Male
  • Neuroprotective Agents / administration & dosage*
  • Organoselenium Compounds / administration & dosage*
  • Ouabain / administration & dosage
  • Oxidative Stress / drug effects*
  • Rats, Wistar
  • Thiazolidines / administration & dosage*

Substances

  • Neuroprotective Agents
  • Organoselenium Compounds
  • Se-phenyl thiazolidine-4-carboselenoate
  • Thiazolidines
  • Ouabain